GO:2000678 negative regulation of transcription regulatory region DNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000678 describes any process that stops, prevents or reduces the binding of proteins to transcription regulatory regions of DNA, thereby tuning gene expression.
• It is a biological_process term that sits upstream of transcriptional repression and is distinct from direct DNA-binding activity itself.
• Key molecular players include TATA-box binding protein (TBP), negative cofactor 2 (NC2), STAT5, PURalpha/PURbeta, MalR, GAL80 and c-Myb.
• Dysregulation of this process contributes to cancer, heart failure and metabolic disease through altered promoter occupancy and gene expression.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate regulators of transcription regulatory region DNA binding.
• EDITGENE provides end-to-end cell model and library screening services to dissect GO:2000678-related mechanisms.
Description
GO:2000678, negative regulation of transcription regulatory region DNA binding, is a Gene Ontology biological_process term that captures any mechanism which stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding. In practical terms, it describes how cells limit the access of transcription factors and cofactors to promoters, enhancers and other regulatory DNA elements, thereby shaping transcriptional output. This process is fundamental to developmental decisions, stress responses and disease-associated gene expression programs. Researchers study GO:2000678 to understand how repressors, co-repressors and chromatin-associated factors control promoter occupancy and to identify therapeutic targets in cancer, cardiac disease and metabolic disorders. The term is mechanistically linked to TBP and its associated family members, which are central to transcription regulation and are themselves targets of negative cofactors such as NC2.
negative regulation of transcription regulatory region DNA binding At A Glance
| GO ID | GO:2000678 |
|---|---|
| GO term | negative regulation of transcription regulatory region DNA binding |
| Ontology | biological_process |
| Synonym | none |
| Major function | Reduces binding of transcription factors and cofactors to regulatory DNA elements, thereby modulating transcription |
| Key regulators | TBP, NC2, STAT5, PURalpha/PURbeta, MalR, GAL80, c-Myb |
| Disease relevance | Cancer, heart failure, metabolic dysregulation |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, ChIP-seq, reporter assays, transcriptomics |
What Is GO:2000678?
In our own words, GO:2000678 refers to any biological process that reduces the binding of proteins to transcription regulatory regions of DNA. It does not describe the DNA-binding activity itself, but rather the regulatory events that decrease the frequency, rate or extent of that binding, leading to altered transcription.
Why Is negative regulation of transcription regulatory region DNA binding Important in Cell Biology?
Understanding GO:2000678 is important because the controlled reduction of transcription regulatory region DNA binding is a central mechanism for gene silencing, feedback control and cell-fate decisions. When this process is disrupted, inappropriate promoter occupancy can drive oncogenic transcription, cardiac remodeling or metabolic imbalance. The term also provides a conceptual framework for interpreting how repressors such as NC2, MalR and GAL80 interfere with TBP or promoter accessibility.
• Controls promoter occupancy and transcriptional output during development and stress.
• Provides a mechanistic basis for gene silencing by repressors and co-repressors.
• Links TBP/NC2 function to global transcription regulation.
• Contributes to cancer biology through altered regulation of genes such as c-myc and c-Myb.
• Implicated in heart failure via PURalpha/PURbeta-mediated repression of alpha-myosin heavy chain.
• Relevant to metabolic gene regulation through MalR in Streptococcus pneumoniae.
• Guides interpretation of ChIP-seq and reporter assays for regulatory DNA binding.
• Supports development of CRISPR models to test causal roles of candidate repressors.
• Helps explain STAT5-dependent trans-activation potential and heterologous transcription factor interactions.
• Offers a framework for therapeutic targeting of aberrant transcription factor binding.
What Happens During negative regulation of transcription regulatory region DNA binding?
Recognition of regulatory DNA by transcription factors
In simple terms: First, transcription factors and cofactors recognize and bind to promoters or enhancers.
Transcription regulatory region DNA binding is initiated when sequence-specific transcription factors and general factors such as TBP recognize promoter or enhancer elements. TBP and associated family members are central to this recognition step and are required for transcription initiation. STAT5 DNA-binding activity and interactions with heterologous transcription factors further illustrate how binding potential is modulated at regulatory regions.
Recruitment of negative cofactors and repressors
In simple terms: Next, repressive factors are recruited to block or reduce that binding.
Negative cofactor 2 (NC2) recognizes the TBP-DNA transcription complex and forms a stable inhibitory complex, directly reducing the productive binding of TBP to regulatory DNA. In Streptococcus pneumoniae, the transcriptional repressor MalR differentially regulates promoters of the maltose/maltodextrin regulon, demonstrating repressor-mediated control of promoter occupancy. Similarly, GAL80 provides an alternative pathway of transcription initiation regulation in yeast by interfering with negative regulatory gene function.
Interference with TBP-DNA complex stability
In simple terms: The repressor can destabilize the TBP-DNA complex so transcription cannot start efficiently.
The crystal structure of NC2 bound to the TBP-DNA complex shows how NC2 recognizes and distorts the complex, preventing productive transcription initiation. This structural mechanism exemplifies how negative regulation of transcription regulatory region DNA binding can occur through direct interference with general transcription factor-DNA complexes.
Sequence-specific repression at promoters and enhancers
In simple terms: Some repressors bind specific DNA elements and compete with or displace activating factors.
PURalpha and PURbeta bind a purine-rich negative regulatory element of the alpha-myosin heavy chain gene and control transcriptional and translational regulation, contributing to repression during heart failure. In the human c-myc gene, transcriptional regulation involves negative regulatory elements that reduce binding of activating factors. c-Myb-induced transcription activation is differentially regulated by a phosphorylation site in its negative regulatory domain, showing how post-translational modification can modulate repressive control.
Integration with signaling and post-translational control
In simple terms: Signals and modifications can tune how strongly binding is reduced.
STAT5 trans-activation potential is regulated through its DNA-binding activity and interactions with heterologous transcription factors, illustrating how signaling inputs can alter regulatory DNA binding. Phosphorylation within the negative regulatory domain of c-Myb modulates its transcriptional activation, providing a mechanism by which post-translational modifications influence negative regulation of transcription regulatory region DNA binding.
Key Genes Involved in GO:2000678 negative regulation of transcription regulatory region DNA binding
The following genes and proteins are experimentally implicated in negative regulation of transcription regulatory region DNA binding, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TBP | General transcription factor that binds TATA-box regulatory DNA | Central target of negative cofactors such as NC2 |
| NC2 | Negative cofactor that recognizes TBP-DNA complex and inhibits transcription | Structural model for negative regulation of regulatory DNA binding |
| STAT5 | Transcription factor whose DNA-binding activity and interactions modulate trans-activation | Signaling-dependent control of regulatory DNA binding |
| PURalpha | Binds purine-rich negative regulatory element of alpha-myosin heavy chain | Repression of alpha-myosin heavy chain during heart failure |
| PURbeta | Binds purine-rich negative regulatory element and controls transcription/translation | Cardiac gene repression model |
| MalR | Transcriptional repressor of maltose/maltodextrin regulon | Differential promoter regulation in Streptococcus pneumoniae |
| GAL80 | Negative regulatory gene in yeast with alternative transcription initiation pathways | Model for repressor-mediated transcription control |
| c-myc | Oncogene with negative regulatory elements controlling transcription | Cancer-related transcriptional regulation |
| c-Myb | Transcription factor with negative regulatory domain modulated by phosphorylation | Phosphorylation-dependent control of transcription activation |
| TBP-associated family members | Assist TBP in transcription regulation | Potential targets for negative regulation |
| NC2 subunits | Form heterodimer that binds TBP-DNA | Structural and functional studies of repression |
| STAT5-interacting factors | Heterologous transcription factors that modulate STAT5 activity | Context-dependent regulatory DNA binding |
| Purine-rich element binding proteins | Recognize negative regulatory elements | Cardiac and translational regulation |
| Maltose regulon promoters | Regulatory DNA bound by MalR | Bacterial repression model |
| GAL80-regulated promoters | Yeast promoters under negative control | Fungal transcription initiation model |
| c-myc regulatory elements | Negative regulatory regions of c-myc | Oncogene repression studies |
| c-Myb negative regulatory domain | Modulates trans-activation | Phosphorylation-site mutant studies |
How Is negative regulation of transcription regulatory region DNA binding Regulated?
Negative regulation of transcription regulatory region DNA binding is itself regulated by signaling pathways and post-translational modifications. STAT5 activity is controlled through its DNA-binding activity and interactions with heterologous transcription factors. Phosphorylation within the negative regulatory domain of c-Myb differentially regulates c-Myb-induced transcription activation. In bacteria, MalR differentially regulates promoters of the maltose/maltodextrin regulon in response to environmental cues. These examples show that the process is dynamically tuned rather than constitutive.
negative regulation of transcription regulatory region DNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| c-myc | Cancer | Knockout or point-mutation of negative regulatory elements in cancer cell lines |
| c-Myb | Cancer / hematopoiesis | Phosphorylation-site point mutants in leukemia cell models |
| PURalpha/PURbeta | Heart failure | Knockout or overexpression in cardiomyocytes |
| STAT5 | Cancer / immune disorders | Knock-in of DNA-binding mutants in hematopoietic cells |
| MalR | Bacterial metabolism | Knockout in Streptococcus pneumoniae |
Cancer
Dysregulated negative regulation of transcription regulatory region DNA binding can lead to inappropriate activation of oncogenes such as c-myc, whose transcription is controlled by negative regulatory elements. c-Myb activity, modulated by phosphorylation in its negative regulatory domain, is also linked to transcriptional programs relevant to cancer.
Heart failure
PURalpha and PURbeta bind a purine-rich negative regulatory element of the alpha-myosin heavy chain gene and control its transcriptional and translational regulation, with implications for repression of alpha-myosin heavy chain during heart failure.
Metabolic and bacterial regulation
In Streptococcus pneumoniae, the transcriptional repressor MalR differentially regulates promoters of the maltose/maltodextrin regulon, illustrating how negative regulation of regulatory DNA binding controls metabolic gene expression.
From negative regulation of transcription regulatory region DNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a repressor increase regulatory DNA binding? | CRISPR knockout of the repressor gene |
| Does a phosphorylation site control repressor activity? | Point mutation at the phosphorylation site |
| Does a disease variant alter promoter occupancy? | Knock-in of the variant allele |
| Where does a repressor bind in the genome? | Tagged knock-in for ChIP-seq |
| Does overexpression of a repressor reduce target gene transcription? | Overexpression cell model |
| Which cofactors cooperate with TBP? | Knockout of TBP-associated family members |
How to Study the negative regulation of transcription regulatory region DNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide DNA binding of transcription factors | Quantify changes in regulatory DNA binding after repressor perturbation |
| Reporter assay | Transcriptional activity of a regulatory element | Test negative regulatory elements from c-myc or alpha-myosin heavy chain |
| RNA-seq | Global gene expression changes | Assess downstream effects of repressor knockout or overexpression |
| Western blot | Protein expression and phosphorylation | Measure c-Myb phosphorylation and STAT5 activity |
| EMSA | In vitro DNA-binding activity | Test TBP or STAT5 binding to regulatory probes |
| Crystallography | Three-dimensional structure of protein-DNA complexes | Study NC2-TBP-DNA interactions |
| CRISPR screening | Phenotypic effects of gene knockout | Identify regulators of transcription regulatory region DNA binding |
Chromatin immunoprecipitation and sequencing (ChIP-seq)
ChIP-seq measures genome-wide binding of transcription factors and cofactors to regulatory DNA, allowing researchers to quantify changes in transcription regulatory region DNA binding upon perturbation of repressors such as NC2 or TBP.
Reporter assays
Reporter assays using regulatory elements from genes such as alpha-myosin heavy chain or c-myc can quantify how negative regulatory elements and their binding proteins modulate transcription.
Transcriptomics (RNA-seq)
RNA-seq measures changes in gene expression following knockout or overexpression of candidate regulators, providing functional readouts of negative regulation of transcription regulatory region DNA binding.
Structural biology
Crystal structures of complexes such as NC2 bound to TBP-DNA reveal the molecular basis of negative regulation and guide mutational studies.
How CRISPR Can Be Used to Study GO:2000678 negative regulation of transcription regulatory region DNA binding
Knockout
CRISPR knockout of candidate repressors such as NC2 subunits, MalR or PUR proteins can test whether loss of the repressor increases transcription regulatory region DNA binding and target gene expression.
Point Mutation
Point mutations at phosphorylation sites in the negative regulatory domain of c-Myb or in DNA-binding domains of STAT5 can dissect how specific residues control negative regulation of transcription regulatory region DNA binding.
Knock-in
Knock-in of disease-associated variants or tagged alleles allows tracking of repressor binding and function at endogenous loci, as exemplified by studies of c-myc regulatory elements and PUR proteins.
Overexpression
Overexpression of repressors such as PURalpha/PURbeta or NC2 can reduce transcription regulatory region DNA binding and repress target genes, providing gain-of-function evidence.
How EDITGENE Supports negative regulation of transcription regulatory region DNA binding Research
Researchers studying negative regulation of transcription regulatory region DNA binding-related genes often need to determine whether a candidate gene is causally involved in controlling promoter occupancy and transcriptional output. EDITGENE provides validated CRISPR cell models and screening services to accelerate this causal testing.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of transcription regulatory region DNA binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SOX11 Knockout HEK293 Cell Line | EDJ-KQ2749 | Human | 6664 | Details Get a Quote |
| SOX11 Knockout HeLa Cell Line | EDJ-KQ54540 | Human | 6664 | Details Get a Quote |
| SOX11 Knockout A-549 Cell Line | EDJ-KQ63024 | Human | 6664 | Details Get a Quote |
| SOX11 Knockout HCT 116 Cell Line | EDJ-KQ71500 | Human | 6664 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records
Frequently Asked Questions About negative regulation of transcription regulatory region DNA binding
What is GO:2000678?
GO:2000678 is the Gene Ontology term for negative regulation of transcription regulatory region DNA binding, describing any process that stops, prevents or reduces the binding of proteins to transcription regulatory regions of DNA.
What genes are involved in negative regulation of transcription regulatory region DNA binding?
Key genes include TBP, NC2, STAT5, PURalpha, PURbeta, MalR, GAL80, c-myc and c-Myb.
How does NC2 negatively regulate transcription regulatory region DNA binding?
NC2 recognizes the TBP-DNA complex and forms a stable inhibitory complex that prevents productive transcription initiation.
What diseases are linked to negative regulation of transcription regulatory region DNA binding?
Cancer, heart failure and metabolic dysregulation have been linked to altered regulation of this process.
How can I study negative regulation of transcription regulatory region DNA binding?
Common methods include ChIP-seq, reporter assays, RNA-seq, EMSA and CRISPR knockout or overexpression models.
What is the role of TBP in this process?
TBP binds TATA-box regulatory DNA and is a central target of negative cofactors such as NC2.
How does phosphorylation affect c-Myb in this context?
Phosphorylation within the negative regulatory domain of c-Myb differentially regulates its transcription activation potential.
What is the role of PUR proteins in heart failure?
PURalpha and PURbeta bind a purine-rich negative regulatory element of alpha-myosin heavy chain and repress its expression during heart failure.
Can CRISPR be used to study GO:2000678?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are widely used to test causal roles of regulators in this process.
What services does EDITGENE offer for GO:2000678 research?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening and bioinformatics services.
Conclusion
GO:2000678, negative regulation of transcription regulatory region DNA binding, is a fundamental biological process that controls promoter occupancy and transcriptional output. Its molecular players, including TBP, NC2, STAT5, PUR proteins, MalR, GAL80 and c-Myb, are implicated in cancer, heart failure and metabolic regulation. CRISPR-based cell models and functional genomics approaches provide powerful tools to dissect this process and identify therapeutic targets.
References
- 1. Mishal R et al.. 2022. Role of the TATA-box binding protein (TBP) and associated family members in transcription regulation.. Gene 833:146581 PMID: 35597524
- 2. Groner B et al.. 2000. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors.. Growth Horm IGF Res 10 Suppl B:S15-20 PMID: 10984248
- 3. Kamada K et al.. 2001. Crystal structure of negative cofactor 2 recognizing the TBP-DNA transcription complex.. Cell 106(1):71-81 PMID: 11461703
- 4. Gupta M et al.. 2003. Single-stranded DNA-binding proteins PURalpha and PURbeta bind to a purine-rich negative regulatory element of the alpha-myosin heavy chain gene and control transcriptional and translational regulation of the gene expression. Implications in the repression of alpha-myosin heavy chain during heart failure.. J Biol Chem 278(45):44935-48 PMID: 12933792
- 5. Nieto C et al.. 1997. The maltose/maltodextrin regulon of Streptococcus pneumoniae. Differential promoter regulation by the transcriptional repressor MalR.. J Biol Chem 272(49):30860-5 PMID: 9388231
- 6. Sakurai H et al.. 1994. Two alternative pathways of transcription initiation in the yeast negative regulatory gene GAL80.. Mol Cell Biol 14(10):6819-28 PMID: 7935399
- 7. Lang JC et al.. 1988. Transcriptional regulation of the human c-myc gene.. Br J Cancer Suppl 9:62-6 PMID: 3076067
- 8. Miglarese MR et al.. 1996. Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain.. J Biol Chem 271(37):22697-705 PMID: 8798443
